Ranking de los programas de inmunización en América Latina, 2019

por Rombini, María Fernanda, Mauas, Romina Paola, Urueña, Analía
Publicado 2022

Cost-Effectiveness Analysis of Switching from Trivalent to Quadrivalent Seasonal Influenza Vaccine in Argentina

por Urueña, Analia, Micone, Paula, Magneres, Cecilia, Mould-Quevedo, Joaquin, Giglio, Norberto
Publicado 2021

1435. The Cost-Effectiveness of Vaccinating With an Adjuvanted Trivalent Influenza Vaccine for the 65+ Population in Argentina

por Nguyen, Van, Vizzotti, Carla, Uruena, Analia, Giglio, Norberto, Magneres, Maria Cecilia, Richmond, Heather
Publicado 2018

Dual therapy with raltegravir plus a fixed dose combination of darunavir/ritonavir in people living with HIV in Argentina

por Rombini, Fernanda, Cecchini, Diego M., Ballivian, Jamile, Huberman, Mara, Urueña, Analía, Cassetti, Isabel
Publicado 2020

Epidemiological study of influenza virus infections in young adult outpatients from Buenos Aires, Argentina

por Santamaría, Cecilia, Urueña, Analía, Videla, Cristina, Suarez, Ariel, Ganduglia, Cecilia, Carballal, Guadalupe, Bonvehi, Pablo, Echavarría, Marcela
Publicado 2008

Meningococcal burden of disease in Argentina: 10 years epidemiologic review

por Neyro, Silvina, Urueña, Analia, Efron, Adriana, Rancaño, Carolina, Pannunzio, Maria E., Seoane, Maria B., Gomez, Jorge A., Giglio, Norberto
Publicado 2023

Cost-Effectiveness Analysis of Cell Versus Egg-Based Seasonal Influenza Vaccination in Children and Adults in Argentina

por Urueña, Analía, Micone, Paula, Magneres, María Cecilia, McGovern, Ian, Mould-Quevedo, Joaquin, Sarmento, Túlio Tadeu Rocha, Giglio, Norberto
Publicado 2022

Single-Dose Universal Hepatitis A Immunization in 1-Year-Old Infants in Argentina: High Prevalence of Protective Antibodies up to 11 Years Following Vaccination

por Urueña, Analia, González, Jorge, Carrega, Maria Eugenia Perez, Rearte, Analía, Uboldi, Andrea, Calli, Rogelio, Cañero-Velasco, María Cristina, Vizzotti, Carla
Publicado 2017

Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion

por Postma, Maarten, Fisman, David, Giglio, Norberto, Márquez-Peláez, Sergio, Nguyen, Van Hung, Pugliese, Andrea, Ruiz-Aragón, Jesús, Urueña, Analia, Mould-Quevedo, Joaquin
Publicado 2023

1166. The Cost-Effectiveness Evidence of Enhanced Influenza Vaccines in Adults ≥65 Years of Age: A Literature Review and Decision-Making Implications

por Giglio, David FismanNorberto, Márquez-Peláez, Sergio, Nguyen, Van, Postma, Maarten, Pugliese, Andrea, Ruiz-Aragón, Jesús, urueña, Analia, Mould-Quevedo, Joaquin F
Publicado 2023

Adverse events and SARS-CoV-2 antibody responses after immunization with Sputnik V, ChAdOx1-S, and BBIBP-CorV vaccines in people with HIV

por Mauas, Romina, Urueña, Analia, Cecchini, Diego, Strada, Maria L., Arietti, Soledad, Cassetti, Isabel, Nogueira, Nicholas F., Salazar, Ana S., Rodriguez, Violeta J., Jones, Deborah L., Alcaide, Maria L.
Publicado 2023

Opinions, Attitudes and Factors Related to SARS-CoV-2 Vaccine Uptake in Eight South American Countries

por Urueña, Analía, Machado, Ricardo, Cunha, Juarez, López Colmano, Clara, Rancaño, Carolina, Kfouri, Renato, Pírez, Catalina, Bonvehí, Pablo, Calvo, Mario, Cuadros, Robinson, Muñoz, Greta, Rodríguez, Mónica, Torres, Jaime, Cahn, Florencia, Ballalai, Isabella
Publicado 2023